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osting by EAbstract Agaricus blazeiMurill is one of the very popular edible medicinal mushrooms. The pres-
ent study investigated the protective effect of this biologically active mushroom on the tissue per-
oxidative damage and abnormal antioxidant levels in carbon tetrachloride induced hepatotoxicity
in male albino rats. Male albino rats of Sprague–Dawley strain weighting (120–150 g) were catego-
rized into ﬁve groups. The ﬁrst group served as the normal control, the second and the third groups
were treated with Agaricus blazei Mushroom extract and carbon tetrachloride dose, respectively.
Fourth group (protective group) was ﬁrst treated with Agaricus blazei Mushroom extract followed
by carbon tetrachloride treatment and ﬁfth (therapeutic group) with carbon tetrachloride ﬁrst
followed by Agaricus blazei Mushroom treatment. The wet fruiting bodies of mushroom Agaricus
blazeiMurill, crushed and suspended in distilled water was administered orally to the treated groups
of male albino rats. The activities of various enzymes (aspartate and alanine transaminase, lactate
dehydrogenase, glutathione reductase), levels of non-enzymatic antioxidants (glutathione, vitamin
C, vitamin E) and level of lipid peroxidation (malondialdehyde) were determined in the serum ofurill; CCl4, carbon tetrachlor-
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304 A.M. Al-Dbass et al.all the experimental animals. Decrease in all the enzymes and non-enzymatic antioxidant, along
with an increase in the lipid peroxidative index (malondialdehyde) was found in all the carbon tet-
rachloride treated rats as compared with normal controls. Also increase level of non-enzymatic anti-
oxidant along with the decrease level in malondialdehyde was found in all experimental animals
which were treated with Agaricus blazei Mushroom extract as compared with normal controls.
The ﬁndings indicate that the extract of Agaricus blazei Murill can protect the liver against carbon
tetrachloride induced oxidative damage in rats and is an efﬁcient hepatoprotective and antioxidant
agent against carbon tetrachloride induced liver injury.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The liver is a vital organ present in vertebrates and some other
animals. It has a wide range of functions such as drug metabo-
lism, amino acid metabolism, lipid metabolism and glycolysis.
Liver is capable of detoxifying toxic substances and synthesiz-
ing useful ones. Hepatotoxic agents can cause very serious dam-
ages to the liver as they may deprive the liver from its principal
functions (Subramoniam and Pushpangadan, 1999). Hepato-
toxic chemicals cause the liver damages which are induced by
lipid peroxidation and other oxidative damages (Muhtaseb
et al., 2008; Appiah et al., 2009). Carbon tetrachloride is used
extensively in experimental models to induce oxidative stress
in rats (Onori et al., 2000; Nabeshima et al., 2006). It is a well
known hepatotoxin that catabolizes radical induced lipid per-
oxidation, damage the membranes of liver cells and organelles
and causes swelling and necrosis of hepatocytes. Carbon tetra-
chloride can induce liver damage through the formation of
reactive free radicals that can bind covalently to cellular macro-
molecules forming nucleic acid, protein and lipid adducts;
through the induction of hypomethylated ribosomal RNA,
resulting in inhibition of protein synthesis. These injuries are
mediated through the formation of reactive intermediates such
as trichloromethyl (CCl3) free radicals and ROS (Lin et al.,
2008). Experimental and clinical results indicate that oxidative
stress may be the link connecting different types of chronic liver
injuries and hepatic ﬁbrosis (Lin et al., 2008). The intracellular
concentration of ROS is a consequence of both their produc-
tion and their removal by various antioxidants. Thus, the anti-
oxidant activity or the inhibition of the generation of free
radicals is important in the protection against CCl4-induced
hepatopathy (Weber et al., 2003; Yuan et al., 2008).
Antioxidative action plays an important role in protecting
the liver against CCl4-induced liver injury (Ardanaz and
Pagano, 2006). Medical treatment for acute and chronic liver
diseases is often difﬁcult to handle and has limited efﬁciency
(Lee et al., 2007). The usage of herbal drugs for the treatment
of liver diseases has increased all over the world. (Girish and
Pradhan, 2008) Developing therapeutically effective agents
from natural products may reduce the risk of toxicity when
the drug is used clinically (Shen et al., 2009). Recent research
has found that mushrooms contain a powerful antioxidant
called l-Ergothioneine. Antioxidants are the heroes of cell pres-
ervation. They work by slowing or preventing the oxidative
process caused by free radicals that can lead to cell damage
and the onset of problems like heart disease and diabetes.
Researchers at the Pennsylvania State Mushroom Research
Laboratory found that mushrooms contain signiﬁcant levels
of Ergothioneine, which has shown antioxidant properties asa scavenger of strong oxidants. Antioxidant activity is en-
hanced by the presence of selenium. A 100 g serving of
uncooked, sliced white mushrooms provides 13% of the Daily
Value for selenium. Ergothioneine is heat-stable, meaning it is
present in both raw and cooked mushrooms. Of the Agaricus
variety, portabella and crimini mushrooms have the most Ergo-
thioneine, followed closely by white mushrooms. Nowadays
mushroom is becoming attractive as a useful food item as it is
low in calories, high in minerals, essential amino acids, vitamins
and ﬁbers (Mattila et al., 2002). Naturally mushrooms are low
in sodium but good source of ﬁber and contain virtually no fat
or cholesterol. Some mushrooms are called as medicinal mush-
rooms and are important source of nutrients and non-toxic
medicines (Wasser and Weis, 1999). In addition, mushrooms
contain virtually no fat or cholesterol. In fact, mushrooms have
been used in folk medicine throughout the world since ancient
times. Many medicinal properties have been attributed to
mushrooms (Borchers et al., 1999) including the inhibition of
platelet aggregation, reduction of blood cholesterol concentra-
tions (Jeong et al., 2010; Aletor and Aladetimi, 1995), preven-
tion or alleviation of heart disease and reduction of blood
glucose levels (Manzi and Pizzoferrato, 2000) and also preven-
tion or alleviation of infections caused by bacterial, viral, fun-
gal and parasitic pathogens (Breene, 1990).
AbM is one of the very popular edible medicinal mush-
rooms which belongs to the family of Basidiomycetes and
has been cultivated especially for the Japanese health food
market. AbM has also been reported to block induced liver li-
pid peroxidation (Lin et al., 1998). In addition AbM has also
been used as a health food for the prevention of a range of ill-
nesses including cancer, diabetes, arteriosclerosis and chronic
hepatitis (Takaku et al., 2001; Itoh et al., 1994). Bactericidal
and fungicidal effects of Agaricus sp. have also been reported
(Vogel et al., 1974; Rosa et al., 2003). The present study was
designed to evaluate the protective and therapeutical actions
of an extract of AbM in an experimental model of CCl4-in-
duced hepatotoxicity in male albino rats, selection of doses
was based on the previous study by (Abdulmajeed, 2007).2. Materials and methods
2.1. Animals
Male albino rats of Sprague–Dawley strain weighting (120–
150 g) were used for this study. Animals were housed in
cleaned metallic cages and were maintained under standard
conditions (23 ± 2 C) and 12 h light/dark cycles). They were
given standard pellet diet and water ad libitum.
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The AbM (Agaricaceae) was cultivated adopting the ‘‘layer
spawning’’ method. Freshly harvested whole mushrooms were
dried in the shade and then ﬁnely powdered. Five grams of the
powder were extracted with 100 ml of 95% ethanol using
Soxhlet apparatus. The residue was ﬁltered and concentrated
to a dry mass by vacuum distillation; the ﬁltrate thus obtained
was used as mushroom extract.
2.3. CCl4-induced hepatotoxicity
CCl4-induced liver injury was administered intraperitoneally in
different groups of rats, except the normal control groups (Gs
1 and 2), using a single necrogenic dose (1.5 ml/kg body weight
of 80% CCl4 in corn oil) according to Pawa and Ali (2004),
which was equivalent to 1/5 of the oral LD50 in mice (Abou
Gabal et al., 2007). Liver injury was evaluated by analyzing
serum obtained from rats sacriﬁced 48 h after receiving the
Hepatotoxic CCl4.
The wet fruiting bodies of the mushroom AbM were
crushed and suspended in distilled water and given orally
through an intragastric tube, in a dose of 0.5 g/kg body weight
daily for 30 days, 48 h either before (G4, as protective group)
or after (G5, as therapeutic group) CCl4 injection.
2.4. Experimental design
Animals were divided into ﬁve groups. The experimental de-
sign and treatment schedule are as follows:
Group 1: Rats did not receive any treatment (normal
healthy control).
Group 2: Rats treated with Agaricus blazei Mushroom
extract only (treated group).
Group 3: Rats treated with CCl4 only (treated group).
Group 4: Rats ﬁrst treated with Agaricus blazei Mushroom
extract followed by CCl4 (protective group).
Group 5: Rats ﬁrst treated with CCl4 followed by Agaricus
blazei Mushroom (therapeutic group).
2.5. Blood collection
At the end of the experimental period, rats in the different
groups were sacriﬁced under ether anesthesia from each rat,
blood samples were collected from the inferior vena cava.
The serum was separated from the blood, and stored at
80 C until analysis.
2.6. Biochemical analysis
2.6.1. Measurement of lactate dehydrogenase (LDH)
The quantities determination of LDH5 was achieved by using
pyruvate to lactate kinetic method, two-point colometric method
for lactate dehydrogenase (LDH) (Wooten and freeman 1982):
PyruvateþNADHþHþ $LDHL LactateþNADþ2.6.2. Determination of transaminase (AST, ALT)
AST was determined on the basis of coupling reaction of
malate dehydrogenase and reduced nictinamide adeninedinucleotide, and ALT was determined on the basis of coupled
reaction of lactate dehydrogenase and reduced nicotinamide
adenine dinucleotide.
Both AST and ALT activities were determined by measur-
ing the rate of oxidation of NADH at 340 nm, the rate of de-
crease in absorbance at 340 nm was proportional to ALT and
AST activities in the sample (Henry, 1974).
2.6.3. Determination of glutathione reductase (GR)
The GR activity was calculated using the method of
Mohandas et al. (1984). GR was assayed by following the oxi-
dation of NADPH at 340 nm.
2.6.4. Determination of lipid peroxides (MDA)
Endogenous lipid peroxidation was assessed by measuring
MDA at 532 nm. Malondialdehyde concentration was calcu-
lated using extinction coefﬁcient value (€) of 156*105 M1cm1
(Buege and Aust, 1978).
2.6.5. Determination of glutathione (GSH)
The reduced glutathione (GSH) was measured by the method
of Bentler et al. (1963) based on its reaction with 5,50-dithiobis
(2-nitrobenzoic acid) to yield the yellow chromophore, 5-thio-
2-nitrobenzoic acid at 412 nm. GSH level is expressed as lmol g–1
tissue.
2.6.6. Determination of vitamin C
Vitamin C was estimated using Folin phenol reagent and the
developed blue color was read at 760 nm (Jagota and Dani,
1982).
2.6.7. Determination of vitamin E
Vitamin E was determined according to Desai and Machlin
(1985) using Bathophenanthroline reagent and the red color
produced was read at 536 nm against blank.
2.7. Statistical analysis
Statistical analysis was done using one-way analysis of vari-
ance (ANOVA). The values are expressed as mean ± S.D. P
value < 0.05 was considered as signiﬁcant.
3. Results and discussion
The effects of AbM on CCl4-induced hepatotoxicity in rats
were evaluated by recording changes in serum LDH5, ALT,
AST, GR, GSH, MDA, vitamin C and vitamin E levels. The
activities of LDH5, ALT, AST and GR in normal and all trea-
ted groups are shown in Table 1 and the activity of GSH,
MDA, vitamin C and vitamin E is shown in Table 2. The data
in Tables 1 and 2 demonstrate a trend of decreased levels of
serum LDH5, ALT, AST, GR, GSH vitamin C and vitamin
E in the CCl4-treated animals compared to the control. This
effect was reversed in the animal groups that were given
AbM only or and during treatment with CCl4 (therapeutic
group, protective group). Malondialdehyde serum levels were
signiﬁcantly elevated in CCl4-treated groups as compared with
control groups. Also in therapeutic group and protective group
where CCl4 was given side by side with mushroom, levels of
malondialdehyde were found higher than control group. On
Table 1 One-way ANOVA test between the control, CCl4-treated, CCl4-treated + then Mushroom dose, Protected by
Mushroom + then CCl4-treated and Protected by Mushroom groups for LDH5, ALT, AST and GR.
Parameters Groups Min. Max. Mean ± S.D. P value
LDH5 (nmol/min/mg prot.) Control 54.76 65.89 59.56 ± 4.32 0.000
CCl4-treated 26.82 33.65 29.33 ± 2.70
a
CCl4-treated + then Mushroom dose 47.49 54.10 50.68 ± 2.49
a
Protected by Mushroom+ then CCl4-treated 55.75 60.30 58.40 ± 1.67
Protected by Mushroom 63.98 68.80 65.64 ± 1.86a
ALT (nmol/min/mg prot.) Control 31.90 37.02 34.16 ± 1.88 0.000
CCl4-treated 14.27 18.62 16.25 ± 1.57
a
CCl4-treated + then Mushroom dose 27.75 30.05 28.67 ± 0.87
a
Protected by Mushroom+ then CCl4-treated 33.27 39.06 35.71 ± 2.19
Protected by Mushroom 37.32 43.45 40.25 ± 2.83a
AST (nmol/min/mg prot.) Control 11.25 13.63 12.29 ± 0.88 0.000
CCl4-treated 4.60 7.17 05.70 ± 0.93
a
CCl4-treated + then Mushroom dose 9.70 11.70 10.49 ± 0.79
a
Protected by Mushroom+ then CCl4-treated 10.40 12.14 11.06 ± 0.70
Protected by Mushroom 9.62 10.68 10.11 ± 0.40a
GR (nmol/min/mg prot.) Control 54.00 60.50 56.33 ± 2.48 0.000
CCl4-treated 35.57 43.40 39.22 ± 2.88
a
CCl4-treated + then Mushroom dose 54.84 60.95 57.99 ± 2.34
Protected by Mushroom+ then CCl4-treated 50.52 58.77 54.86 ± 3.00
Protected by Mushroom 52.80 60.60 56.58 ± 2.92
Groups and Dunnett test as multiple comparisons. Signiﬁcant levels between the four groups are illustrated as superscripts letters when
P< 0.05.
Table 2 Describes the one-way ANOVA test between the Control, CCl4-treated, CCl4-treated + then Mushroom dose, Protected by
Mushroom + then CCl4-treated and Protected by Mushroom for Vitamin C, Vitamin E, MDA and GSH.
Parameters Groups Min. Max. Mean ± S.D. P value
Vit. C (mg/g) Control 312.00 382.00 347.33 ± 28.58 0.000
CCl4-treated 204.00 248.50 228.12 ± 16.06
a
CCl4-treated + then Mushroom dose 310.00 376.00 350.38 ± 24.52
Protected by Mushroom+ then CCl4-treated 285.00 330.00 305.63 ± 16.24
a
Protected by Mushroom 318.00 332.00 324.68 ± 05.10
Vit. E (mg/g) Control 0.69 0.79 0.74 ± 0.03 0.000
CCl4-treated 0.29 0.43 0.35 ± 0.05
a
CCl4-treated + then Mushroom dose 0.67 0.72 0.70 ± 0.02
Protected by Mushroom+ then CCl4-treated 0.74 0.78 0.76 ± 0.01
Protected by Mushroom 0.71 0.78 0.75 ± 0.02
MDA (nmol/mg prot.) Control 3.49 4.20 03.92 ± 0.29 0.000
CCl4-treated 10.53 12.55 11.36 ± 0.77
a
CCl4-treated + then Mushroom dose 4.76 5.25 04.99 ± 0.18
a
Protected by Mushroom+ then CCl4-treated 4.24 4.89 04.56 ± 0.24
Protected by Mushroom 3.15 4.24 03.73 ± 0.42
GSH (nmol/mg prot.) Control 22.80 25.90 24.32 ± 1.13 0.000
CCl4-treated 13.30 15.90 14.65 ± 1.02
a
CCl4-treated + then Mushroom dose 20.10 23.40 22.42 ± 1.36
Protected by Mushroom+ then CCl4-treated 21.90 25.51 23.19 ± 1.43
Protected by Mushroom 25.11 27.69 26.58 ± 0.99a
Groups and Dunnett test as multiple comparisons. Signiﬁcant levels between the four groups are illustrated as superscripts letters when
P< 0.05.
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alone remained within the levels of the control group. Percent-
age change of all the above mentioned enzymes in all the ﬁve
groups are shown in Figs. 1 and 2.Carbon tetrachloride is a well-known hepatotoxic agent. It
causes signiﬁcant increases in serum levels of ALT, AST and
LDH5 and centrilobular hepatocellular vacuolar degeneration
and necrosis (Trivedi and Mowat, 1983; Berman et al., 1992).
Figure 1 Percentage change of LDH, ALT, AST and GR in CCl4-treated, CCl4-treated + then Mushroom dose, Protected by
Mushroom + then CCl4-treated and Protected by Mushroom groups compared to control.
Figure 2 Percentage change of Vit. C, Vit. E, MDA and GSH in CCl4-treated, CCl4-treated + then Mushroom dose, Protected by
Mushroom + then CCl4-treated and Protected by Mushroom groups compared to control.
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damage became more severe (Trivedi and Mowat, 1983; Al-
Ghamdi, 2003). Furthermore, its effect on rats is age depen-
dent and much less severe in old rats than in young adult rats
(Rikans et al., 1994). In the present study, the dose of CCl4 was
very high which may explain the contrary trend of decreased
serum transaminases (ALT and AST) and LDH5 (LDH isoen-
zymes which synthesized by liver) which are probably due to
decreased synthesis resulting from extensive damage of the
hepatic cells. This could be supported by the previous study
by Al-Ghamdi (2003). This damage appeared to inhibit or
modulate by administration of AbM indicating restoration of
hepatic cell function.Liver damage is always associated with cellular necrosis,
and depletion of reduced liver glutathione. In our study oxida-
tive stress was evidenced by decreased GSH, GR which is iden-
tical to as reported by Khan et al. (2011) and with the
increased production of malondialdehyde in all CCl4-treated
animals which were opposite, what was found in animals trea-
ted with AbM alone or AbM in treatment with CCl4 (therapeu-
tic group, protective group). It is well known that GSH is a
major non-enzymatic antioxidant and plays an important role
in cellular defense, which is a crucial determinant of tissue sus-
ceptibility to oxidative damage (Meister and Anderson, 1983;
Prescott, 1982. GSH depletion occurs as a consequence of
CCl4-induced toxicity. Non-enzymic antioxidants such as
308 A.M. Al-Dbass et al.reduced glutathione, vitamin C and vitamin E play an excellent
role in protecting the cells from oxidative damage (Aldrige,
1981; Pesh-Imam and Reckuagel, 1977). It is well established
that GSH in blood keeps up the cellular levels of the active
forms of vitamin C and vitamin E by neutralizing the free rad-
icals. When there is a reduction in the GSH content the cellular
levels of vitamin C is also lowered, indicating that GSH, vita-
min C, and vitamin E are closely interlinked to each other
(Winkler, 1992). Lipid per oxidation is one of the major char-
acteristic of oxidative damage in accordance with the data
obtained from our study CCl4 administration results in a sig-
niﬁcant elevation of malondialdehyde production. Malondial-
dehyde is commonly used as marker of free radical mediated
lipid peroxidation injury (Amin and Ghoneim, 2009). Mal-
ondialdehyde level in serum of CCl4-treated group was signif-
icantly elevated compared to that in normal group while in all
the groups treated with mushroom extracted resulted in signif-
icant decrease in malondialdehyde levels. Izawa and Inoue
(2004) suggested that AbM extracts contain a complex mixture
of antioxidants and other substances that may act synergically
for reducing free radicals. Huang and Mau (2006) reported
naturally antioxidant composites in methanolic extracts of
AbM such as ascorbic acid, tocopherol and total phenols.
Administration of AbM extract in all the experimental animals
may have increased the levels of these antioxidants in the ser-
um. In the present study AbM muchrooms showed protective
effect against liver damage by CCl4-induced toxicity which is
purported by the result of Abdulmajeed (2007).
4. Conclusions
In conclusion, the data achieved by this study revealed that
AbM is a natural source of antioxidant compounds and have
hepatoprotective activities against CCl4-induced liver damage.
However, further studies may still be needed to clarify its ef-
fects on ALT and AST and LDH5.
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